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DURING DEVELOPMENT
Late first trimester: from 10 to 14 weeks of gestational age
-Strong expression of NPAS3 is detected in the developing central nervous system
nucleus of cells of the ventricular zone.
-Weaker level of expression in other zones, such as the lung, viscera and heart.
Early second trimester: 14 weeks of gestational age
-Ventricular and periventricular zone.
- Increasing expression in the cerebellum, which develops between the third and
fourth month of fetal life.
From second trimester (23 WGA) to late-third trimester
-Cortical expression of NPAS3 increases as the cortical layers develop.
-Strongly expressed in the nucleus of cells of the hippocampal dentate gyrus (DG)
during the third trimester and in the stratum radiatum of CA1 area of the
hippocampus.
IN THE ADULT
INTERNEURONS: These neurons are linked to adult neurogenesis through
neurotransmitters like GABA, and through different signaling molecules: NPAS3,
reelin, apoE, and SDF-1 and its receptor CXCR4.
• Family in which disruption of NPAS3 on chromosome 14q13
segregates with disease.
• NPAS3 knockout mice display several schizophrenia-like behavioral
abnormalities such as, impaired social recognition, deficits in learning
tests, stereotypic behavior at weaning, and increased locomotor
activity in the Open Field paradigm.
• Reduction of hippocampal reelin and the FGF-2 receptor expression in
NPAS3 knockout mice.
• These mice feature a marked reduction (85%) in hippocampal adultPOST-TRANSLATIONAL REGULATION
• Photomicrographs of a section through the CA1
area of the hippocampus double-labeled for NPAS3
(Right) and reelin (Left). Arrows indicate double-
labeled cells that show that reelin colocalizes with
NPAS3 expressing neurons.
1. INTRODUCTION
4. ASSOCIATION WITH SCHIZOPHRENIA
3. NPAS3 EXPRESSION
Scientific literature search on PubMed database: Selection of recent papers and reviews
on this database according to their quality and data of publication.




- Correlation with psychiatric illness
The transcription factor NPAS3 is a member of the basic helix-loop-helix family of proteins.
It is expressed by GABAergic interneurons, in particular, NPAS3 co-localizes with calretinin-
expressing and reelin-producing interneuron subtypes.
It has a 90% of evolutionary conservation among mammals, which suggests a crucial role in
neurodevelopment, neoplasia and neurobehaviour; and it contains the largest cluster of
noncoding-accelerated regions in the human genome, suggesting a contribution in human
brain evolution.
AIM: This review will try to characterize this gene and its functional role, as well as analyze
different regulating factors and the pathologies derived from its altered function.
2. MATERIALS AND METHODS
(Adapted from Erbel-Sieler et al, 2004)
Decreased  adult hippocampal cell proliferation (Adapted from Pieper et al, 2005)
neurogenesis correlating with the thickness of the granule cell layer.
A) No significant differences were detected in the levels of NPAS3 mRNA between healthy
brains and brains of people suffering schizophrenia.
B) A difference in NPAS3 protein expression was detected among healthy females and females
with schizophrenia.
C) miR-17 levels were increased in  the prefrontal cortex of people with schizophrenia.
:
Indicated by lack of correlation between the levels of NPAS3 mRNA and NPAS3 protein expression.
• Co-localization with DCX, a marker of neuron-restricted progenitors, indicates a
participation of NPAS3 in a later, post-proliferative, stage of neuronal differentiation
NPAS3 mediates production of new neurons critical to growth or maintenance of
the hippocampus throughout development and adulthood.
• NPAS3 has post-translational regulation and it targets other genes with important roles
in neurogenesis to regulate their expression.
• It is one of the many putative risk factors for schizophrenia. This gene shows an
important field of study for the cure of schizophrenia and probably other related
psychiatric illnesses such as bipolar disorder and depression.
•Treatments: - NPAS3 is a SNP associated with iloperidone efficacy for schizophrenia
- Administration of P7C3 corrected hippocampal neurogenesis deficits                     
in Npas3-NULL mice.
• Mice that lacked NPAS3 
were deficient in FGF-1 
receptor mRNA and had
85% less adult
hippocampal cell
proliferation than wild type
mice. 
• Central infusion of FGF-2 
was unable to elevate
hippocampal cell
proliferation in NPAS3 
knockout mice. 
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